FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Spectrum Laboratory Products Ranitidine Hydrochloride Recall

Ranitidine Hydrochloride (powder), USP, Rx only, Spectrum Chemical Mfg Corp

Spectrum Laboratory Products · Gardena, CA

Risk level
Class II
Reported by FDA
Feb 12, 2020
Recall ID
D-0825-2020
Check your lot numberHow we source this data

Summary

Spectrum Laboratory Products recalled Ranitidine Hydrochloride starting Jan 14, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0825-2020 on Feb 12, 2020. Reason: CGMP Deviations: Presence of NDMA impurity detected in product. Status: Terminated.

Why it was recalled

CGMP Deviations: Presence of NDMA impurity detected in product.

Product description

Ranitidine Hydrochloride (powder), USP, Rx only, Spectrum Chemical Mfg Corp., a) 1 gram, b) 5 grams, c) 25 grams, d)100 grams, e) 500 grams, f) 1 Kilogram

Lot numbers, UPCs & expiration codes

Lot #:11E0585, Exp. October 2023

Where it was sold

The recalled API was distributed to pharmacies in the following states: AZ, CA, FL, GA, NJ, PA, RI, SC, TX, UT, WY. The API was also distributed internationally to Canada and UAE.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0825-2020
Classification
Class II
Status
Terminated
Recall initiated
Jan 14, 2020
FDA report date
Feb 12, 2020
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Spectrum Laboratory Products

Original FDA data

Every field from FDA enforcement report D-0825-2020, exactly as published.

Show all FDA fields
City
Gardena
State
CA
Status
Terminated
Country
United States
Event ID
84799
Address
14422 S San Pedro St
Code information
Lot #:11E0585, Exp. October 2023
Postal code
90248-2027
Report date
Feb 12, 2020
Product type
Drugs
Recall number
D-0825-2020
Classification
Class II
Recalling firm
Spectrum Laboratory Products
Termination date
Dec 5, 2023
Reason for recall
CGMP Deviations: Presence of NDMA impurity detected in product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ranitidine Hydrochloride (powder), USP, Rx only, Spectrum Chemical Mfg Corp., a) 1 gram, b) 5 grams, c) 25 grams, d)100 grams, e) 500 grams, f) 1 Kilogram
Distribution pattern
The recalled API was distributed to pharmacies in the following states: AZ, CA, FL, GA, NJ, PA, RI, SC, TX, UT, WY. The API was also distributed internationally to Canada and UAE.
Recall initiation date
Jan 14, 2020
Initial firm notification
Letter
Center classification date
Feb 4, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0825-2020, published Feb 12, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls